In an analogous manner, RB1 loss may mediate upregulation of epigenetic and stem cell reprogramming factors in EGFR-mutant LUAD, facilitating SCLC transformation and acquired EGFR TKI resistance. Here, RB1 is linked to small cell lung carcinoma.